Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer’s Disease
Neurotherapeutics - United States
doi 10.1007/s13311-016-0511-x
Full Text
Open PDFAbstract
Available in full text
Date
January 30, 2017
Authors
Publisher
Springer Science and Business Media LLC